AGE-SPECIFIC INCIDENCE AND OUTCOME OF SEPSIS IN THE US
Explore this paper's citation graph
- Type
- article
- Published
- 1999-01-01
- Cited by
- 52
- References
- 0
- OpenAlex
- https://openalex.org/W1977032474
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:71585838
Keywords
Medicine, Incidence (geometry), Sepsis, Outcome (game theory), Intensive care medicine
References
No references recorded for this paper.
Cited by
- Guidance on patient identification and administration of recombinant human activated protein C for the treatment of severe sepsis.
- Quel avenir pour les médicaments de l’hémostase dans le traitement du sepsis sévère après le Xigris® ?
- The coagulopathy of sepsis: pathophysiology and management.
- Rethinking Sepsis: From Concepts to Syndromes to Diseases
- Drotrecogin Alfa (Activated): The First Fda-Approved Treatment for Severe Sepsis
- Impacto de un programa educacional en la sepsis grave y shock séptico
- Science review: Natriuretic peptides in critical illness
- Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis
- Introduction: Strategies for Prevention and Treatment of Sepsis in Post-Surgical Intensive Care
- Protein C levels as a prognostic indicator of outcome in sepsis and related diseases
- Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis
- Coagulation dysfunction in sepsis and multiple organ system failure.
- Macrophage migration inhibitory factor.
- Clinical Nurse Specialists: State of the Profession and Challenges Ahead
- Infection in obstetric critical care.
- Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure
- Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis.
- Clinical Experience with Drotrecogin Alfa in Treating Gram-Positive and -Negative Pathogens in Patients with Severe Sepsis
- Epidemiology of sepsis: An update
- Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis.
Related papers
- Evaluation of Follow-up Impact of the Honoured Outcome under the Quasi-Purchase System of Research Outcome
- Correlation of Clinical Sepsis Definitions with Microbiological Characteristics in Patients Admitted Through a Sepsis Alert System; A Prospective Cohort Study
- Sepsis-3-the use of sepsis in children: we still have a lot of work to do
- A systematic investigation on animal models of cyclosporine A combined with Escherichia coli to simulate the immunosuppressive status of sepsis patients before onset
- Sepsis
- Acute increases of O‐GlcNAcylation reduces sepsis‐associated mortality (837.8)
- Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates
- Research Progress of Ferroptosis in Septic Organ Damage
- Potential of glucocorticoids to treat intestinal inflammation during sepsis.
- Earlier Recognition of Sepsis and Septic Shock With SEPSIS-3 Criteria - It's Still Early Days!